Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

H&R Block Extends Emerald Advance Line Of Credit Offer Through Jan. 24

RELATED NEWS
Trade HRB now with 

H&R Block Inc. (HRB: Quote) announced that it will extend its Emerald Advance line of credit offer through January 24. The company said that due to consumer need and limited options for unbanked consumers to obtain credit, it will continue to accept applications from current and new clients in more than 10,000 participating offices nationwide.

H&R Block Emerald Advance line of credit and H&R Block Emerald Savings® are offered through, and H&R Block Emerald Prepaid MasterCard is issued by, H&R Block Bank, a Federal Savings Bank, Member FDIC. Line of credit is subject to credit and underwriting approval.

Click here to receive FREE breaking news email alerts for H&R Block Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.